Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCE™ (60mg pre-filled syringe ...

Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCEtm (60mg pre-filled syringe) and XBRYKtm (120mg vial), denosumab biosimilars ...

Less than half of patients had undergone bone monitoring, suggesting a need for better clinical guidance and management of ...

A new case report was published in Oncoscience's Volume 12 on February 4, 2025, titled “Breaking point: Systemic mastocytosis manifesting as severe osteoporosis.” ...

Feb. 10, 2025 — Rapid weight loss affects muscle mass and can increase the risk of osteoporosis. But now there is good news for people taking weight loss medication who may be at risk.

Co-Chief Emeritus of the spine service at HSS, Harvinder Sandhu, M.D., told OTW, “Historically, depression is associated with ...

Mereo BioPharma shifts focus to rare diseases with setrusumab showing strong results for Osteogenesis Imperfecta. Learn more on MREO stock here.

We live in a world where sitting for hours is normal—working at desks, watching TV, or scrolling on phones. It might feel ...

Romosozumab plus alendronate led to a greater improvement in bone strength than alendronate alone in postmenopausal women ...

Treatment with romosozumab led to improvements in bone microarchitecture among postmenopausal women with osteoporosis.

The pregnant driver of a broken down car was left with a spinal fracture after another driver ploughed into her stationary vehicle at around 60mph on a busy East Renfrewshire Road. The woman's car was ...